Funding Campaign Halfway to Goal for StarSense

Funding Campaign Halfway to Goal for StarSense

November 7, 2020, Lawrence, MA – Rubix LS has announced today that it is nearly halfway towards it funding goal of $1M, at $450,000, for its lead platform, StarSense, a virtual clinical trial platform that has been piloted in the utility of patient testing for...
Rubix LS on Pharma Tech Outlook

Rubix LS on Pharma Tech Outlook

Recently our Founder and CEO, Reginald Swift, sat down with the team at Pharma Tech Outlook magazine to discuss the changes happening with the pharma industry and how digital health, particularly virtual clinical trials are mobilizing access of pipeline therapeutics...
What we’re doing for the COVID-19 crisis…

What we’re doing for the COVID-19 crisis…

In the wake of the current COVID-19 crisis plaguing the world, many life science and health technology organizations are mobilizing ways to assist in containing and managing patient symptoms as well as racing toward a vaccine. While the world is approximately 12-18...